Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2021 Financial Results and Provides Financial Expectations for Fiscal 2022
Go back to Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2021 Financial Results and Provides Financial Expectations for Fiscal 2022| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 161.44 -0.18 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.62 | 52 Week High | $58.46 | |||
| Open | $161.62 | 52 Week Low | $31.25 | |||
| Day High | $163.53 | P/E | N/A | |||
| Day Low | $160.42 | EPS | $-0.69 | |||
| Volume | 1,076,139 | |||||
